NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner
about
NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
NVX-412, a new oncology drug c ...... ls in a p53-independent manner
@ast
NVX-412, a new oncology drug c ...... ls in a p53-independent manner
@en
NVX-412, a new oncology drug c ...... ls in a p53-independent manner
@nl
type
label
NVX-412, a new oncology drug c ...... ls in a p53-independent manner
@ast
NVX-412, a new oncology drug c ...... ls in a p53-independent manner
@en
NVX-412, a new oncology drug c ...... ls in a p53-independent manner
@nl
prefLabel
NVX-412, a new oncology drug c ...... ls in a p53-independent manner
@ast
NVX-412, a new oncology drug c ...... ls in a p53-independent manner
@en
NVX-412, a new oncology drug c ...... ls in a p53-independent manner
@nl
P2093
P2860
P1433
P1476
NVX-412, a new oncology drug c ...... ls in a p53-independent manner
@en
P2093
Alexandra Hebar
Barbara C Rütgen
Edgar Selzer
P2860
P304
P356
10.1371/JOURNAL.PONE.0045015
P407
P577
2012-01-01T00:00:00Z